Interleukin-21 Inhibits HBV Replication in vitro

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Antiviral Therapy

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3851/IMP2950PMID 25774942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

  2014cited by this paper
• Interleukin‐21 mediates hepatitis B virus‐associated liver cirrhosis by activating hepatic stellate cells

  2014cited by this paper
• Chronic Hepatitis B Monitoring and Treatment Patterns in Five European Countries with Different Access and Reimbursement Policies

  2014cited by this paper
• Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes

  2014cited by this paper
• Replication-Competent Infectious Hepatitis B Virus Vectors Carrying Substantially Sized Transgenes by Redesigned Viral Polymerase Translation

  2013cited by this paper
• Duck HBV Dna Copy Numbers in Isolated Hepatocyte Nuclei Vary Dramatically and Decline during Entecavir Therapy

  2013cited by this paper
• Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

  2013cited by this paper
• IL-21 Promotes CD8+ CTL Activity via the Transcription Factor T-bet

  2013cited by this paper
• Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions

  2013cited by this paper
• Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection

  2013cited by this paper
• Il-21R Gene Polymorphisms and Serum Il-21 Levels Predict Virological Response to Interferon-Based Therapy in Asian Chronic Hepatitis C Patients

  2013cited by this paper
• IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B.

  2011cited by this paper
• Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase

  2011cited by this paper
• Hepatitis B virus infection.

  2009cited by this paper
• Management of hepatitis B in China.

  2009cited by this paper
• CD8+ T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions

  2009cited by this paper
• A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection

  2009cited by this paper
• Interferon-inducible antiviral effectors

  2008cited by this paper
• Hepatitis B virus infection.

  2008cited by this paper
• Interleukin-21: basic biology and implications for cancer and autoimmunity.

  2008cited by this paper
• IL-10, T cell exhaustion and viral persistence.

  2007cited by this paper
• Induction of Regulatory T-Cells and Interleukin-10-Producing Cells in Non-Responders to Pegylated Interferon-α Therapy for Chronic Hepatitis B

  2007cited by this paper
• Differential role of IL‐2R signaling for CD8+ T cell responses in acute and chronic viral infections

  2007cited by this paper
• IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.

  2007cited by this paper
• Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.

  2006cited by this paper
• Interleukin-10 determines viral clearance or persistence in vivo

  2006cited by this paper
• Resolution of a chronic viral infection after interleukin-10 receptor blockade

  2006cited by this paper
• Association between chronic hepatitis B virus infection and interleukin‐10, tumor necrosis factor‐α gene promoter polymorphisms

  2006cited by this paper
• Dynamics of hepatitis B virus clearance in chimpanzees.

  2005cited by this paper
• Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees

  2004cited by this paper
• CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection

  2003cited by this paper
• IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells.

  2003cited by this paper
• Inhibitory activity of dioxolane purine analogs on wild‐type and lamivudine‐resistant mutants of hepadnaviruses

  2002cited by this paper
• Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.

  2000cited by this paper
• Viral clearance without destruction of infected cells during acute HBV infection.

  1999cited by this paper
• Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

  1996cited by this paper
• Two distinct types of hepatitis in experimental hepatitis B virus infection.

  1980cited by this paper
• Management of hepatitis.

  1969influential reference

• Impact of hepatic steatosis on mortality, hepatocellular carcinoma, end-stage liver disease and HBsAg seroclearance in chronic hepatitis B: a United States cohort study

  2025cites this paper
• A greater frequency of circulating CCR7loPD-1hi follicular helper T cells indicates a durable clinical cure after Peg IFN-α therapy in chronic hepatitis B patients

  2025cites this paper
• Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink

  2024cites this paper
• Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis

  2024cites this paper
• The Role of Interleukins in HBV Infection: A Narrative Review

  2023cites this paper
• A Meta-Analysis of the Association Between Genetic Polymorphisms in IL-12, IL-17, and IL-21 and Risk of Hepatitis B Virus Infection

  2023cites this paper
• NAFLD and HBV interplay - related mechanisms underlying liver disease progression

  2022cites this paper
• Hepatitis B Virus-Specific Cellular Immunity Contributes to the Outcome of Occult Hepatitis B Virus Infection

  2022cites this paper
• IL-21 Is Associated With Virological Relapse of HBeAg Positive Chronic Hepatitis B After Discontinuance of Entecavir.

  2021cites this paper
• Serum IL-21 levels predict HBeAg decline during rescue therapy in patients with partial response to nucleos(t)ide analogues

  2021cites this paper
• Present and Future Therapies for Chronic Hepatitis B.

  2020cites this paper
• Immunological Features of AECHB

  2019cites this paper
• Acute Exacerbation of Chronic Hepatitis B: Volume 1. Definition, Research Technology, Virology, Genetics and Immunology

  2019cites this paper
• Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)–Specific CD8+ T Cells in Chronic HBV Infection

  2018cites this paper
• [A recombinant adenovirus vector carrying murine interleukin-21 gene controls chronic HBV infection in mice].

  2017cites this paper
• Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease

  2016cites this paper
• Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

  2015cites this paper